Format

Send to

Choose Destination
Eur Heart J. 2016 Feb 7;37(6):510-9. doi: 10.1093/eurheartj/ehv721. Epub 2016 Jan 3.

The year in cardiology 2015: prevention.

Author information

1
National Institute for Health and Medical Research (INSERM), Dyslipidemia and Atherosclerosis Research, Pitié-Salpêtrière University Hospital, Paris FR-75651, France University of Pierre and Marie Curie, Paris, France john.chapman@upmc.fr.
2
Clinic for Cardiology, University Heart Center Hamburg, German Center for Cardiovascular Research (DZHK), Hamburg, Germany.
3
Department of Cardiology, Charité Universitätsmedizin Berlin (CBF), Berlin, Germany German Center for Cardiovascular Research (DZHK), Berlin Institute of Health (BIH), Berlin, Germany.
PMID:
26726043
PMCID:
PMC5053187
DOI:
10.1093/eurheartj/ehv721
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

M.J.C. has received research funding from CSL, Kowa, MSD, Pfizer and Randox Laboratories, and honoraria for participation in Speakers Bureaux and Advisory Boards of Amgen, AstraZeneca, Kowa, Merck, Pfizer, Sanofi-Regeneron, and Unilever. U.L. has received lecture/advisory board honoraria or research funding from Roche, Sanofi, Amgen, MSD, Pfizer, Servier, Menarini, Astra, St Jude, Orbus&Neich, and Terumo. S.B. reports no disclosures. S.B. has received research funding from Abbott, Abbott Diagnostics, Bayer, Boehringer Ingelheim, SIEMENS and Thermo Fisher. He received honoraria for lectures from Abbott, Abbott Diagnostics, Astra Zeneca, Bayer, Boehringer Ingelheim, Medtronic, Pfizer, Roche, SIEMENS Diagnostics, SIEMENS, Thermo Fisher and as member of Advisory Boards and for consulting for Boehringer Ingelheim, Bayer, Novartis, Roche and Thermo Fisher.

Supplemental Content

Full text links

Icon for Silverchair Information Systems Icon for PubMed Central
Loading ...
Support Center